Sean A. McCarthy, CEO at CytomX Therapeutics, Inc. (CTMX), sold 237,938 shares at $6.42 ($1.5M) on 2026-03-17, disclosed to the SEC on 2026-03-19.
Seasonal sale ($1.5M) by CEO — this insider has traded CTMX in March in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.42 | 118,969 | $764K | 50.0% |
| 2 | $6.42 | 118,969 | $764K | 50.0% |
| Total | $6.42 avg | 237,938 | $1.5M | 100% |
| Filing → |
| CTMX | SELL | 2025-06-17 | $299K | — | Filing → |
| CTMX | SELL | 2025-03-20 | $23K | — | Filing → |
| CTMX | SELL | 2024-08-22 | $17K | — | Filing → |